Wave Life Sciences Ltd. (WVE)
6.365
+0.22
(+3.66%)
USD |
NASDAQ |
May 20, 10:23
Wave Life Sciences Shareholders Equity (Quarterly) : 511.73M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novo Nordisk A/S | 31.31B |
| Eli Lilly & Co. | 31.20B |
| GSK Plc | 23.54B |
| Jazz Pharmaceuticals Plc | 4.532B |
| Merck & Co., Inc. | 45.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 583.54M |
| Total Liabilities (Quarterly) | 71.81M |
| Debt to Equity Ratio | 0.0307 |
| Current Ratio | 11.26 |
| Net Debt Paydown Yield | 0.14% |